CRIO Selected for Fully Virtual Decentralized Clinical Trial

CRIO and strategic partner Jiva Science are providing eSource, Telehealth, eConsent and ePRO in support of a Major Depressive Disorder (MDD) virtual trial

BOSTON, Aug. 23, 2022 – CRIO, a Boston-based healthcare technology firm streamlining clinical trials for sponsors, sites, and patients, has been selected as the eSource vendor for a 200 patient MDD trial. The study will consist of virtual investigators who will conduct the trial using a combination of Telehealth and CRIO’s eSource system.

“CRIO’s eSource platform is a foundation for decentralized clinical trials, enabling remote capture of eSource during a clinical trial. Along with our strategic partner, Jiva Science, which is providing the Telehealth and ePRO solutions, CRIO will be able to deliver a fully virtual trial,” says Raymond Nomizu, CEO and co-founder at CRIO. “We are changing the way that clinical trials are run across a wide range of indications. Sponsors are looking for new and innovative ways to conduct clinical research, and CRIO is at the forefront of this evolution.”

“CRIO was an ideal choice for this study. Our eSource and virtual platform align with our vision of conducting clinical trials of the future, today,” says Kristen Bosse, director of product development at CRIO. “CRIO’s model of capturing data once during the clinical trial process will enable our sponsor client to conduct this trial with patients residing anywhere in the U.S.”

About CRIO

Innovation is at the heart of everything we do. Our mission is to streamline clinical research to bring new medications to market faster. We have created a holistic paperless platform for conducting clinical trials that reduces data errors, streamlines regulatory workflows and accelerates timelines. Today, CRIO supports more than 2,000 medical research sites worldwide. For more information about CRIO, visit clinicalresearch.io.

CRIO Bugathon – Building the Ultimate Platform

While bugs are as natural in coding as they are in nature, we don’t want them creeping into our code. At CRIO, we have established various processes and procedures to handle bugs. At the close of 2022, we hosted a Bugathon, part of our ongoing efforts to deliver best-in-class quality. The Bugathon was a two...

CRIO Welcomes Dr. Margaretta Nyilas to its Board of Directors

BOSTON, MA – November 3, 2022 – CRIO, the industry’s leading eSource provider, announces the appointment of Dr. Margaretta Nyilas to its Board of Directors, effective immediately. Dr. Nyilas is a biopharmaceutical executive with over twenty years of diverse global industry experience, formerly at Otsuka Pharmaceuticals, Bristol Myers Squibb and Click Therapeutics. She has a...

3 Reasons to Visit CRIO at SCRS 2022

SCRS 2022 starts next week. Here are 3 reasons to stop by Booth 401 and meet Team CRIO. We’ll see you there! Friday, Oct.7 at 10:30 am. Master Workshop #1 : How the World’s Leading Vaccine Network Reduced Protocol Deviations by 40% 2. Meet the team behind the industry’s leading site-based eSource technology. CRIO delivers...